共 98 条
[51]
Murphy CA(2009)Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells J Invest Dermatol 129 1022-10 e1-306
[52]
Nakae S(2009)Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes J Allergy Clin Immunol 124 2876-56
[53]
Ruutu M(2010)Role of Th17 cells in human autoimmune arthritis Arthritis Rheum 62 1190-36
[54]
Benham H(2012)Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis N Engl J Med 366 2295-9
[55]
Lories RJ(2014)Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis N Engl J Med 370 349-86
[56]
Jacques P(2014)Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial Ann Rheum Dis 73 3828-8
[57]
Nograles KE(2014)Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody J Immunol 192 1914-9
[58]
Liang SC(2002)The T cell receptor repertoire in psoriatic synovitis is restricted and T lymphocytes expressing the same TCR are present in joint and skin lesions J Rheumatol 29 2878-60
[59]
Raychaudhuri SP(2001)Psoriatic arthritis joint fluids are characterised by CD8 and CD4 T cell clonal expansions appear antigen driven J Immunol 166 470-6
[60]
Raychaudhuri SK(2010)HIV-associated psoriasis: pathogenesis, clinical features, and management Lancet Infect Dis 10 33-84